Latin America Rapid Point-of-care Testing For Sickle Cell Anemia Market Size & Outlook
Related Markets
Latin America rapid point-of-care testing for sickle cell anemia market highlights
- The Latin America rapid point-of-care testing for sickle cell anemia market generated a revenue of USD 14.2 million in 2025.
- The market is expected to grow at a CAGR of 9.2% from 2026 to 2033.
- In terms of segment, lateral flow immunoassay was the largest revenue generating type in 2025.
- Paper-Based Rapid Diagnostics is the most lucrative type segment registering the fastest growth during the forecast period.
- Country-wise, Brazil is expected to register the highest CAGR from 2026 to 2033.
Latin America data book summary
| Market revenue in 2025 | USD 14.2 million |
| Market revenue in 2033 | USD 28.1 million |
| Growth rate | 9.2% (CAGR from 2026 to 2033) |
| Largest segment | Lateral flow immunoassay |
| Fastest growing segment | Paper-Based Rapid Diagnostics |
| Historical data covered | 2021 - 2024 |
| Base year for estimation | 2025 |
| Forecast period covered | 2026 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Lateral Flow Immunoassay, Paper-Based Rapid Diagnostics, Others Type |
| Key market players worldwide | BioMedomics, Silver Lake Research, Bio-Rad Laboratories Inc, Trivitron Healthcare, Hemex Health, Sysmex Corporation, EKF Diagnostics Holdings PLC, Danaher Corp |
Other key industry trends
- In terms of revenue, Latin America region accounted for 4.3% of the global rapid point-of-care testing for sickle cell anemia market in 2025.
- Globally, North America is projected to lead the regional market in terms of revenue in 2033.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 167.3 million by 2033.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Rapid Point-of-Care Testing for Sickle Cell Anemia Market Scope
Rapid Point-of-Care Testing for Sickle Cell Anemia Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Hemex Health | View profile | 1-10 | Portland, Oregon, United States, North America | http://hemexhealth.com/ |
| Silver Lake Research | View profile | 11-50 | Azusa, California, United States, North America | https://www.silverlakeresearch.com/ |
| Halcyon Biomedical | View profile | - | Friendswood, Texas, United States, North America | http://halcyonbiomedical.com |
| BioMedomics | View profile | 1-10 | Morrisville, North Carolina, United States, North America | http://biomedomics.com |
| Transasia Bio Medicals | View profile | 1001-5000 | Mumbai, Maharashtra, India, Asia | http://www.transasia.co.in |
| Trivitron Healthcare | View profile | 5001-10000 | Chennai, Tamil Nadu, India, Asia | http://www.trivitron.com |
| Mylab Discovery Solutions | View profile | 11-50 | Lonavla, Maharashtra, India, Asia | https://mylabdiscoverysolutions.com/ |
| Sysmex Corp | View profile | 10448 | 1-5-1 Wakinohara-Kaigandori, Chuo-ku, Hyogo Prefecture, Kobe, Japan, 6510073 | http://www.sysmex.co.jp |
| EKF Diagnostics Holdings PLC | View profile | 356 | 19 Stanwell Road, Penarth, Avon House, Cardiff, United Kingdom, CF64 2EZ | https://www.ekfdiagnostics.com |
| Bio-Rad Laboratories Inc | View profile | 8030 | 1000 Alfred Nobel Drive, Hercules, CA, United States, 94547 | https://www.bio-rad.com |
| Danaher Corp | View profile | 63000 | 2200 Pennsylvania Avenue, N.W., Suite 800W, Washington, DC, United States, 20037-1701 | https://www.danaher.com |
Latin America rapid point-of-care testing for sickle cell anemia market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to rapid point-of-care testing for sickle cell anemia market will help companies and investors design strategic landscapes.
Lateral flow immunoassay was the largest segment with a revenue share of 55.63% in 2025. Horizon Databook has segmented the Latin America rapid point-of-care testing for sickle cell anemia market based on lateral flow immunoassay, paper-based rapid diagnostics, others type covering the revenue growth of each sub-segment from 2021 to 2033.
The Latin American market for rapid point-of-care (POC) testing for sickle cell anemia is witnessing increasing attention due to the region's growing focus on genetic blood disorders and improved diagnostic infrastructure.
Although sickle cell disease (SCD) has traditionally been underdiagnosed in many Latin American countries, recent public health initiatives and a growing awareness of hemoglobinopathies are driving demand for accessible and early diagnostics—especially POC solutions that bypass the need for sophisticated laboratory setups.
Countries such as Brazil and Argentina are at the forefront of this development due to their relatively higher prevalence of SCD among Afro-descendant and mixed-ethnicity populations. For instance, Brazil alone accounts for the highest number of SCD cases in Latin America, with an estimated 3,500 children born with the disease each year.
Reasons to subscribe to Latin America rapid point-of-care testing for sickle cell anemia market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Latin America rapid point-of-care testing for sickle cell anemia market databook
-
Our clientele includes a mix of rapid point-of-care testing for sickle cell anemia market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Latin America rapid point-of-care testing for sickle cell anemia market , including forecasts for subscribers. This continent databook contains high-level insights into Latin America rapid point-of-care testing for sickle cell anemia market from 2021 to 2033, including revenue numbers, major trends, and company profiles.
Partial client list
Latin America rapid point-of-care testing for sickle cell anemia market size, by country, 2021-2033 (US$M)
Latin America Rapid Point-of-Care Testing for Sickle Cell Anemia Market Outlook Share, 2025 & 2033 (US$M)
Related industry reports
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
